ArticleRadiology. Imaging cancer2024
Open access · diamondAbstract read
In one paragraph
Article in Radiology. Imaging cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 citations in OpenAlex.
- Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial.Nature communications · 2026Trial
- De-Escalation of Neoadjuvant Treatment for HER2-Positive Breast Cancer.International journal of cancer · 2026Review
- First-in-Human Imaging Results of PHAROS: A Versatile High-Resolution TOF/DOI PET Scanner for Brain, Breast, and Extremity Imaging.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026Article
- Comparison of changes in dynamic contrast-enhanced magnetic resonance imaging and flourine-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters from baseline to post-neoadjuvant therapy in predicting pathological response in breast cancer.Diagnostic and interventional radiology (Ankara, Turkey) · 2026Article
- Can the Newer Model of Breast-Specific Positron Emission Tomography Reduce the "Blind Area"?Diagnostics (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 1 institution in 1 country.
Devan DiwanjiFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).
Natsuko OnishiFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).
Deep K HathiFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).
Courtney Lawhn-HeathFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).ORCID 0000-0002-1088-3463
John KornakFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).ORCID 0000-0002-0089-0619
Wen LiFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).ORCID 0000-0001-6584-363X
Ruby GuoFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).
Julissa Molina-VegaFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).
Youngho SeoFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).
Robert R FlavellFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).ORCID 0000-0002-8694-1199
Diane HeditsianFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).
Susie BrainFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).
Laura J EssermanFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).ORCID 0000-0001-9202-4568
Bonnie N JoeFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).ORCID 0000-0001-9333-1463
Nola M HyltonFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).ORCID 0000-0002-6747-1662
Ella F JonesFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).
Kimberly M RayFrom the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).ORCID 0000-0002-8030-9563
University of California System · US
Funding
The I SPY 2.2 TRIAL: Evolving to Imaging and Molecular Biomarker Response Directed Adaptive Sequential Treatment to Optimize Breast Cancer OutcomesP01CA210961 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANGELA DEMICHELE · 2017 to 2026
$22.9MReal-time In Vivo MRI Biomarkers for Breast Cancer Pre-Operative Treatment TrialsR01CA132870 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HYLTON-WATSON, NOLA M., NEWITT, DAVID C · 2008 to 2019
$4.8MDedicated breast PET and MRI for characterization of breast cancer and its response to therapyR01CA227763 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Natsuko Onishi Yamashita · 2019 to 2026
$3.6MQuantitative Imaging for Assessing Breast Cancer Response to TreatmentU01CA225427 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HYLTON-WATSON, NOLA M. · 2018 to 2022
$3.2MInvestigating oncogenic mutations and regulatory mechanisms of HER2 by electron microscopyF30CA247147 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DIWANJI, DEVAN · 2020 to 2023
$163kNCI NIH HHS F30 CA247147NCI NIH HHS P01 CA210961NCI NIH HHS R01 CA132870NCI NIH HHS R01 CA227763NCI NIH HHS U01 CA225427
Abstract
Purpose To compare quantitative measures of tumor metabolism and perfusion using fluorine 18 (
Indexed as
Breast NeoplasmsFluorodeoxyglucose F18FemaleHumansKi-67 AntigenMagnetic Resonance ImagingNeoadjuvant TherapyPositron-Emission TomographyFluorodeoxyglucose F18Ki-67 AntigenBreastDynamic Contrast-enhanced MRIPET
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.